For the year ending 2025-12-31, ORMP made $2,000K in revenue. $64,050K in net income. Net profit margin of 3202.50%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenues | 2,000 | - | ||
| Cost of revenue | 1,987 | - | ||
| Gross profit | 13 | - | ||
| Research and development expenses | 6,381 | 6,324 | ||
| General and administrative expenses | 8,720 | 6,457 | ||
| Operating loss | -15,088 | -12,781 | ||
| Other income, net | 958 | - | ||
| Financial income (loss), net (note 17) | 89,454 | -2,286 | ||
| Interest expenses (note 11b) | - | 853 | ||
| Income (loss) before tax expenses | 75,324 | -15,920 | ||
| Tax expenses | 11,308 | 3,183 | ||
| Net income (loss) | 64,016 | - | ||
| Non-controlling interests | -34 | - | ||
| Companys stockholders | 64,050 | -19,103 | ||
| Basic EPS | 1.53 | -0.48 | ||
| Diluted EPS | 1.5 | -0.48 | ||
| Basic Average Shares | 41,402,997 | 40,828,380 | ||
| Diluted Average Shares | 42,418,644 | 40,828,380 | ||
ORAMED PHARMACEUTICALS INC. (ORMP)
ORAMED PHARMACEUTICALS INC. (ORMP)